Dietary supplement and method of treatment for diabetic control
AssigneeAkesis Pharmaceuticals
InventorStuart A. Fine
Life of this patent
Estimating the term…
Abstract
A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes anchor components of Chromium Polynicotinate and Picolinate, Vanadyl Sulfate, Vitamin E Natural, Standardized Willow Bark (aspirin), and Magnesium Chloride, Citrate, Fumarate, Malate, Glutorate, and Succinate Complex, Folic Acid, and Alpha-Lipoic Acid.
Claims39
A dietary supplement for improving glucose metabolism, comprising:
- a. a bioavailable source of chromium in amount of at least about 200 mcg;
- b. a bioavailable source of vanadium in amount of at least about 10 mg;
- and,
- c. a bioavailable source of aspirin in amount of at least about 20 mg of aspirin.
An ingestible formulation for improving glucose metabolism in a subject with abnormal glucose metabolism, comprising:
- a. a bioavailable source of chromium in a complex and amount that delivers an effective amount of chromium for improving glucose metabolism;
- and
- b. a bioavailable source of vanadium in a complex and amount that delivers an effective amount of vanadium for improving glucose metabolism,
- c. a bioavailable source of aspirin in an amount that delivers an effective amount of aspirin,
- wherein said amount of said complex of said bioavailable source of chromium is no less than about 200 mcg, said amount of said complex of said bioavailable source of vanadium is no less than about 10 mg, and said amount of said bioavailable source of aspirin is no less than 20 mg of aspirin.
A method for improving glucose metabolism, comprising administering to a patient a dietary supplement comprising:
- a bioavailable source of chromium in a complex and amount that delivers an effective amount of chromium, a bioavailable source of vanadium in a complex and amount that delivers an effective amount of vanadium, and a bioavailable source of aspirin in an amount that delivers an effective amount of aspirin, wherein said amount of said complex of said bioavailable source of chromium delivers no less than about 200 mcg, said amount of said complex of said bioavailable source of vanadium delivers no less than about 10 mg, and said amount of said bioavailable source of aspirin delivers no less than about 20 mg of aspirin.
Dependencies are inferred from the claim text.